ENBRAFY
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jan 2020)
What this means for you
This application is over — abandoned 20 Jan 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87077422
- Mark type
- Stylized text
- Filed
- 20 Jun 2016
- Published for opposition
- 25 Oct 2016
- Abandoned
- 20 Jan 2020
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma
Owner
- Array Biopharma Inc., Boulder, CO, US
- Array Biopharma Inc., Boulder, CO, US
Prosecution history
- 21 Jan 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Jan 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 15 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2019 — SOU EXTENSION 5 GRANTED
- 07 May 2019 — SOU EXTENSION 5 FILED
- 10 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 May 2019 — SOU TEAS EXTENSION RECEIVED
- 22 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Dec 2018 — SOU EXTENSION 4 GRANTED
- 20 Dec 2018 — SOU EXTENSION 4 FILED
- 20 Dec 2018 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2018 — SOU EXTENSION 3 GRANTED
- 18 Jun 2018 — SOU EXTENSION 3 FILED
- 18 Jun 2018 — SOU TEAS EXTENSION RECEIVED